|
|
In-Person Registration | Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway in Breast CancerThis activity is intended for medical and radiation oncologists, hematologists, hematology-oncology fellows, general and breast surgeons and other healthcare providers involved in the treatment of breast cancer. You are now registering as a practicing physician, fellow, nurse or other healthcare provider involved in the treatment of cancer. If you are not a clinician in practice, please register as a nonclinician.
|